Rokitamycin in genital infections due to Chlamydia and Mycoplasma. Trial controlled versus josamycin;Trattamento delle infezioni genitali da Chlamydia e Mycoplasma con rokitamicina. Studio controllato vs josamicina

Minerva Ginecologica

Volumn 50, Issue 11, 1998, Pages 491-497

  Colombo, U ^a   Pifarotti, G ^a,b   Amidani, M ^a   Viezzoli, T ^a   Pifarotti, P ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Clinica Ostetrica e Ginecologica   (Italy)

Author keywords

Chlamydia trachomatis; Genital infections; Josamycin; Mycoplasma hominis; Rokitamycin

Indexed keywords

JOSAMYCIN; ROKITAMYCIN;

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERABILITY; DYSURIA; ERYTHEMA; FEMALE; FEMALE GENITAL TRACT INFECTION; GENITAL TRACT INFECTION; HUMAN; MALE; MALE GENITAL TRACT INFECTION; MYCOPLASMA HOMINIS; ORAL DRUG ADMINISTRATION; POLLAKISURIA; PRURITUS; RANDOMIZED CONTROLLED TRIAL;

ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; JOSAMYCIN; MIOCAMYCIN; MYCOPLASMA HOMINIS; MYCOPLASMA INFECTIONS;

EID: 0031739912     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Johnson AM, Grun L, Haines A. Controlling genital chlamydial infection. Br Med J 1996,313:1160.
2. Handsfield HH, Jasman LL, Roberts PL, Hanson VW, Kothenbeutel RL, Stamm WE. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA 1986;255: 1730-4.
3. Centers for Disease Control and Prevention. Recommendations for the prevention and management of Chlamydia tracbomatis infection. MMWR 1993;42:1-37.
4. Westrom L Incidence, prevalence and trends of acute pelvic inflammatory disease and its consequences in industrialised countries Am J Obstet Gynecol 1980.138: 880-92.
5. Taylor-Robinson D Chlamydia trachomatis and sexually transmitted disease. Br Med J 1994;308:150-1
6. Taylor-Robinson D Tests for infection with Chlamydia trachomatis. Int J STD AIDS 1996;7:19-26
7. Lee H, Chernesky MA, Schacter J. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995,345:213-6.
8. Ridgeway GL, Mumtaz G, Robinson AJ Comparison of the ligase chain reaction with cell culture for the diagnosis of Chlamydia trachomatis infection in women. J Clin Pathol 1996;49:116-9
9. Oostergaard L, Moller JK, Andersen B, Olesen F. Diagnosis of urogenital Chlamydia trachomatis infection in women based on mailed samples obtained at home: multipractice comparative study. Br Med J 1996, 313,1186-9.
10. Quinn TC, Gaydos C, Sheperd M. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnership. JAMA 1996:276(21).1737-42
11. Farmaci per le malattie a trasmissione sessuale In: Guida alla terapia antimicrobica. The Medical Letter on Drugs and Therapeutics, Edizione aggiornata 1996: 57-65
12. Magdid D, Douglas JMJ, Schwartz JS. Doxycycline compared with azichromycin for treating women with genital Chlamydia trachomatis infection- an incremental cost-effectiveness analysis. Ann Intern Med 1996,124: 389-99.
13. Hara K, Rokitamycin. Jpn J Antibiot 1987;40(11).1851.
14. Cocuzza CE, Lanzafame S, Cogo R, Matlina R In vitro antibacterial activity of rokitamycin compared to other macrolides. Proceedings of the 9° Congr Medit Chemiot Milano, 1994.
15. Cocuzza CE, Goglio A, Mattina R, Nicoletti PL, Piacentini I, Rescaldini R et al Attività antibatterica in vitro di alcuni macrolidi su ceppi di S. pyogenes eritromicina-resistenti. Proceedings of the 4° Congr Sezione Siculo Sardo Calabra della Società Italians di Microbiologia. Giardini Naxos (Messina). 1996:abs n 38
16. th ICAAC, Los Angeles: 1988.abs n. 904.
17. Hardy DJ, Hensey DM, Beyer JM, Vojtko C, McDonald EJ, Fernandes PB. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob Agents Chemother 1988;32(11) 1710-9.
18. Akita H, Sunakawa K, Motohiro T. Fuji R. The usefulness of rokitamycin dry syrup in the treatment of chlamydial infections in neonates, premature infants and infants. Int J Exptl Clin Chemot 1990;3(4):187-200.
19. Casin I, Bianchi A, Scieux C, Perol Y. In vitro comparative activity of rokitamycin, erithromycin and josamycin against Neisseria gonorrhoeae, Chlamydia trachomatis and genital Mycoplasma. Proceedings of the 7th Mediterranean Congr Chemotherapy. Barcelona. 1990.
20. Masaki M, Dohtsu Y, Masuyama Y Penetration of macrolides into polymorphonuclear leukocytes (PMNS). Chemotherapy 1987;35(9):709-13
21. Ishiguro M, Koga H, Kohno S, Hayashi T, Yamaguchi K, Hirota M, Penetration of macrolides into human polymorphonuclear leukocytes. J Antimicrob Chemo-ther 1989;24:719-29.
22. Torre D, Broggini M, Bottà V, Sampietro C, Busarello R, Garben C. In vitro and ex vivo effects of recent and new macrolide antibiotics on chemotaxis of human polymorphonuclear leukocytes. J Chemother 1991;3(4): 236-9.
23. Broggini M, Benvenuti C, Fonio W, Botta V, Congedo M, Parini J. Pharmacokinetics of rokitamycin after single administration to healthy volunteers. Eur J Drug Metab Pharmacokinet 1991;16(2):137-40
24. Neuman N, Macrolidi, lincosamidi. streptogramine. In: De Simone C, editor. Vademecum degli antibiotici ed agenti chemioterapici anti-infettivi. Roma: Sigma-Tau Ed, 1990:313-56.
25. Morishita M, Ohno M, Sumita Y, Soejima R. Formulation design of rokitamycin tablet and its evaluation. Proceedings of the 14th ICC, Rec Adv in Chemother 1985;1429-30.
26. Bono AV, Lovisolo J, Vio P. La rokitamicina nelle uretriti da Chlamydia trachomatis (CT). Esperienza clinica. Proceedings oh the 68° Congr Naz Soc It Urol. Roma, 1995:abs 137